Literature DB >> 8347331

Autopsy in dementing illness: who participates?

L E Harrell1, R Callaway, R Powers.   

Abstract

The frequency of occurrence of various types of dementing disorders has been ascertained primarily from autopsied series. Since autopsy is voluntary, it is unknown if these series are representative of the entire demented population. To assess this issue, all deaths occurring over a 5-year period in our Memory Disorders Clinic were reviewed, and clinical variables and diagnoses were compared between patients who were autopsied and those who were not. Sixty-nine patients died; 43% (n = 30) underwent autopsy, and 57% (n = 39) did not. Race (no black patients were autopsied), age of disease onset, age of presentation to the clinic, age of death, and interval between last clinic contact and death (significantly less for nonautopsied patients) were found to differ between the two groups. However, clinical diagnosis of dementia was similar in the two groups. The clinical diagnosis was confirmed in 84% of autopsied patients. These results suggest that there are no major differences between clinical diagnoses for autopsied and non-autopsied patients and that the frequency of occurrence of various dementias obtained through autopsied series are representative of the demented population.

Entities:  

Mesh:

Year:  1993        PMID: 8347331     DOI: 10.1097/00002093-199307020-00003

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  7 in total

1.  Clinical aspects of Alzheimer's disease in black and white patients.

Authors:  R Hargrave; M Stoeklin; M Haan; B Reed
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

2.  Factors associated with African American and White elders' participation in a brain donation program.

Authors:  Angela L Jefferson; Susan Lambe; Elana Cook; Monique Pimontel; Joseph Palmisano; Christine Chaisson
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

3.  Evaluation of selection bias in an incident-based dementia autopsy case series.

Authors:  Debby Tsuang; Kate L Simpson; Gail Li; Ross L Barnhart; Steven D Edland; James Bowen; Wayne McCormick; Linda Teri; David Nochlin; Eric B Larson; Mary Lou Thompson; James B Leverenz
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Apr-Jun       Impact factor: 2.703

4.  Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.

Authors:  Robert G Riekse; James B Leverenz; Wayne McCormick; James D Bowen; Linda Teri; David Nochlin; Kate Simpson; Charisma Eugenio; Eric B Larson; Debby Tsuang
Journal:  J Am Geriatr Soc       Date:  2004-09       Impact factor: 5.562

Review 5.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

6.  Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.

Authors:  David X Thomas; Sumali Bajaj; Kevin McRae-McKee; Christoforos Hadjichrysanthou; Roy M Anderson; John Collinge
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

7.  Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.

Authors:  Kurt D Christensen; J Scott Roberts; Charmaine D M Royal; Grace-Ann Fasaye; Thomas Obisesan; L Adrienne Cupples; Peter J Whitehouse; Melissa Barber Butson; Erin Linnenbringer; Norman R Relkin; Lindsay Farrer; Robert Cook-Deegan; Robert C Green
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.